Deriva Energy Collaborating with Brookfield to Deliver Renewable Power to Microsoft
CHARLOTTE, N.C., May 6, 2024 /PRNewswire/ -- Deriva Energy, a Brookfield portfolio company, is pleased to announce its participation in the recently announced global renewable energy framework agreement between Brookfield and Microsoft Corporation to deliver over 10.5 gigawatts of renewable energy to Microsoft worldwide. As a participant in the arrangement, Deriva will be positioned to deliver a sizeable portion of Microsoft's renewable energy capacity across the US.
Deriva will be positioned to deliver a sizeable portion of Microsoft's renewable energy capacity across the US.
The agreement provides Microsoft with access to a pipeline of new renewable energy capacity to support the growing demand for cloud services at home and at work. Through it, Brookfield and its portfolio companies, including Deriva, will accelerate the decarbonization of the electric grid and the global shift to renewable energy.
About Deriva Energy
Deriva Energy, formerly Duke Energy Renewables, is an established leader in clean energy, with 5,900 megawatts of operating and under construction wind, utility-scale solar, and storage assets across the U.S. As a Brookfield portfolio company, Deriva joins one of the world's largest owners and operators of renewable power and climate transition assets. Deriva empowers customers with innovative clean energy solutions that strengthen communities and serve future generations. Deriva is headquartered in Charlotte, North Carolina. For more information, visit: www.DerivaEnergy.com.
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024).
The campaign focuses on access to IBD care and treatment as the burden of...
The global industrial automation market in life sciences industry size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.4% during the forecast period. ...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...